Oxford–AstraZeneca COVID-19 vaccine
Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca
Oxford–AstraZeneca COVID-19 vaccine ▸ Facts ▸ Comments ▸ News ▸ Videos
UK revises travel policy, implies issue is India's vaccine certificate | Covishield | Oneindia News
Credit: Oneindia Duration: 01:40Published
India to retaliate against new jab policy of United Kingdom for travelers | Oneindia News
Credit: Oneindia Duration: 01:52Published
PM promotes Covid jab to sceptical Brazilian president
Credit: ODN Duration: 01:21Published
Joe Biden urges Afghan leaders to fight against Taliban | Withdrawing US troops | Oneindia News
Credit: Oneindia Duration: 02:26Published
ICMR study suggests mixing Covaxin and Covishield can work better against Covid-19 | Oneindia News
Credit: Oneindia Duration: 01:17Published
Creator of Oxford vaccine made into Barbie doll
Credit: PA - Press Association STUDIO Duration: 01:07Published
Rahul Gandhi on nine-year-old girl's rape: Dalit child nation's daughter too| Oneindia News
Credit: Oneindia Duration: 03:00Published
You Might Like
No change in Covishield dose gap: NTAGI chiefDr N K Arora, chairman of the Covid-19 working group of National Technical Advisory Group on Immunisation (NTAGI), on Saturday ruled out any changes in the gap between two doses of Covishield citing..
Italy recognises Covishield; travellers jabbed in India eligible for Green Pass: Indian embassy in RomeItaly has become the latest EU member to recognise WHO-approved Covishield, after several others like Germany, Switzerland, France and Spain. Indian vaccine card holders are now eligible for GreenPass,..
No technical concern in Covishield certificate process, says UK in sign of conciliation
Covishield: Neither side raised concerns with each other’s certification process, says UK envoy
Centre files plea against allowing second dose of Covishield earlier, says it will derail policy
Covishield approved in UK, travel advisory revised after strong objections from IndiaThe UK has revised its vaccine policy for travelers from India, and Covishield jabs have been approved in the travel advisory.
India warns UK of reciprocal steps over vaccine ‘discrimination’“Covishield is a licensed product of the UK company, manufactured in India of which we have supplied five million doses to the UK,” said Shringla, pointing to the inconsistency in the rules..
India says UK govt's stand on Covishield 'discriminatory', warns of 'reciprocal action'
Faceoff: UK's non-recognition of Covishield creates storm on TwitterThe UK government’s new international travel rules putting those who are vaccinated with Covishield in the category of the 'unvaccinated' have been blasted as "offensive", "bizarre" and "racist".
India to protest against new UK vaccine travel rules not recognising CovishieldExternal Affairs Minister S Jaishankar is likely to speak to the newly-appointed British Foreign Secretary Liz Truss on UK not recognising Covishield.
Centre places purchase order with Serum Institute for 66 crore Covishield doses to be supplied by Dec: Sources
Allow second Covishield dose after 4 weeks from first for those who want it early: Kerala HC to Centre
Covishield, Covaxin & Sputnik V: You can now identify COVID-19 fake vaccines with these stepsIndia is currently administering 3 vaccines - Covidshield, Covaxin and Sputnik V. Here are some ways in which you can identify if the vaccine is fake
84 days gap between Covishield vaccine doses provides best protection against COVID-19: CentreThe duration of 84 days between first and second doses of the Covishield COVID-19 vaccine gives the best protection against coronavirus, Centre said
Fake Covishield doses in Southeast Asia, Africa: UP govt issues alert to all DMs, CMOsThe Uttar Pradesh government has issued an alert after fake Covishield doses were found in Southeast Asia and Africa.
No plan yet to revise Covishield dose gap, clarifies govt
Government mulls reducing time gap between Covishield doses, say sources
Majority Indians experienced no or mild side effects post 2 doses of Covishield and Covaxin: Report
COVID-19: Gap between two doses of Covishield may be reducedAt present, over 59 crore vaccine doses have been administered in the country and efforts are being made by the government to expedite the process.
84-day gap in Covishield doses due to efficacy or availability? Kerala HC asks CentreJustice PB Suresh Kumar said that if efficacy was the reason, he was "worried" as he got the second dose within four-six weeks of the first dose.
Kerala man files plea in court for Covishield after taking both doses of Covaxin, read whyThe man Girikumar, 50 had filed a plea in the Kerala High Court stating that he works in Saudi Arabia which is yet to recognise the Covaxin.
DCGI gives nod to conduct study on mixing Covaxin, CovishieldThe Drugs Controller General of India (DCGI) has given approval to conduct a study on mixing Covaxin and Covishield vaccines. The research study will be done by Christian Medical College, Vellore, said..
Permission granted to CMC Vellore to mix vaccine doses for research study: Dr V K PaulDCGI has approved a proposal from the CMC Vellore to carry out trials on the mixed use of COVID-19 vaccines, Covishield and Covaxin in people.
Covishield-Covaxin mix offers better shield, says ICMR studyThe study examined 18 individuals in UP who inadvertently received Covishield as the first jab and Covaxin as the second. "The findings suggest that immunisation with a combination of an adenovirus..
136 crore Covishield, Covaxin doses to lead India's vaccination drive during August-DecemberMore than 136 crore Covid-19 vaccine doses are expected to be available till the end of this year, informed the Centre. For the next four months, India's vaccine programme will be accelerated by the..
Government likely to reduce Covishield dose gap but are you eligible? Find answerThe decision to increase the gap of dosage to 12-16 weeks was met with criticism as the move was interpreted as an attempt to manage vaccine scarcity.
CDSCO expert panel recommends nod to study on mixing doses of Covaxin, CovishieldAn expert panel of India's central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a clinical trial of mixing of two Covid-19..
Covishield generates 93% protection, says AFMC studyCovishield generated 93% protection against Covid, whereas mortality due to the infection came down by 98% during the second wave which was driven by Delta variant, officials said citing a vaccine..
Covishield reduces fresh infections by 93%, deaths by 98%: AFMS studyA study by Armed Forces Medical Services (AFMS) has found that Covishield vaccine reduces fresh COVID-19 infections by 93 per cent and deaths by 98 per cent, the Defence Ministry said on Tuesday.
NTAGI recommendation to increase gap between Covishield doses based on scientific evidence: GovtThe recommendation of an expert panel on Covid to increase the gap between Covishield doses was made based on scientific evidence in a transparent manner, the government informed Rajya Sabha on..
France accepts travellers vaccinated with India's manufactured Covishield - Check full list of countriesThe European Union only recognises AstraZeneca manufactured vaccines as a certificate for COVID-19 travel
17 European nations have given nod to Covishield: Serum Institute of India
15 of 27 member countries of the EU have approved Covishield: Poonawalla
No application received from SII for EU authorisation of Covishield vaccine: EMAPoonawalla last month said that he was 'taking this up at the highest levels with regulators and diplomats' and that he hoped to resolve this matter.
Also reported by •IndiaTimes
Government buying Covishield at Rs 215, Covaxin at Rs 225The fresh vaccine orders placed by the Centre are at a revised price of Rs 215 for Covishield and Rs 225 for a dose of Covaxin, according to an official source. “We are on path to achieving the..
Government orders 66 crore vaccine doses worth Rs 14,505 croreThe government is placing its largest order yet of Covid vaccines at 66 crore doses worth Rs 14,505 crore to procure Covishield and Covaxin shots that will help it to substantially meet the vaccine..
Switzerland, Iceland, 7 EU nations approve Covishield for travel entrySwitzerland, Iceland and seven EU countries have approved Covishield, the AstraZeneca vaccine manufactured by Serum Institute of India, a day after India threatened to put European visitors under..
India's request to EU: Consider Covishield, Covaxin under 'Green passport' scheme or face reciprocal policyControversy unfolded over EU's move to not include India's Covishield and Covaxin under its 'Green Passport' scheme for its Digital COVID Certificate.
Adar Poonawalla says EU green pass Covishield issue has been ‘blown out of proportion’Serum Institute of India CEO Adar Poonawalla played down on Wednesday Covishield not getting approved for the EU green pass, saying, "It is not a controversy at all. It’s been blown out of..
Won't recognise your vaccine certificates if you don't include Covaxin, Covishield: India to EUIndia will not recognise EU’s digital covid certificate until the EU includes Indian vaccines Covishield and Covaxin in the certificate. In what is certainly the first diplomatic retaliatory..
'Matter of time': SII's Poonawalla confident of getting EU green pass for CovishieldSerum Institute of India (SII) CEO Adar Poonawalla on Wednesday said that the European approval for its locally manufactured Covishield vaccine is "just a matter of time" and is expected in about a..
Indians in a fix, Jaishankar raises green pass for Covishield with EU
Covishield becomes collateral damage in inter-EU tussle over Chinese vaccinesEMA has listed 4 vaccines, which are Comirnaty (Pfizer), Janssen, Spikevax (previously COVID-19 Vaccine Moderna), and AstraZeneca's Vaxzevria.
India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soonIndia on Tuesday cleared the decks for the import of Moderna's Covid vaccine, adding another option to its list of anti-Covid shots. Moderna's vaccine, developed in the United States, will be the..
Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India: SourcesIndia's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's Covid-19 vaccine for restricted emergency use in the country, official sources said..
France 'actively working' on Indian concerns over Covishield's absence on EU Green PassFor market authorization of Covishield for use in the EU, the SII needs to apply for EMA, which then conducts a verification of the production site.
EU agency clarifies on Covishield nod
Covishield not a ‘green pass’, Europe-bound Indians fretBENGALURU: The exclusion of Covishield, AstraZeneca’s Covid-19 vaccine manufactured by Pune-based Serum Institute of India, from the European Union’s Covid ‘Green Pass’ has left hundreds of..
SII seeks govt help for adding Covishield in EU vax passport list
Approval to Covishield would be considered should we receive marketing authorisation application: EU agencyThe Covishield vaccine "does not currently have a marketing authorisation" in Europe and the matter would be considered when an application is received for it, the European Medicines Agency (EMA) said..